Format

Send to

Choose Destination
Radiol Clin North Am. 2013 Sep;51(5):781-98. doi: 10.1016/j.rcl.2013.06.003.

Role of positron emission tomography/computed tomography in breast cancer.

Author information

1
University of Tennessee Medical Center, 1924 Alcoa Highway, Knoxville, TN 37920, USA.

Abstract

Although positron emission tomography (PET) imaging may not be used in the diagnosis of breast cancer, the use of PET/computed tomography is imperative in all aspects of breast cancer staging, treatment, and follow-up. PET will continue to be relevant in personalized medicine because accurate tumor status will be even more critical during and after the transition from a generic metabolic agent to receptor imaging. Positron emission mammography is an imaging proposition that may have benefits in lower doses, but its use is limited without new radiopharmaceuticals.

KEYWORDS:

Breast cancer; Computed tomography; Positron emission mammography; Positron emission tomography

PMID:
24010906
DOI:
10.1016/j.rcl.2013.06.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center